“The ISET-CTC test was developed by Professor Paterlini-Brechot in France about 20 years ago, is a cytology-based blood test using microscopy – a 100-year old clinically validated technique to identify cancer cells and used in oncology all around the world. This ISET-CTC test is superior in its sensitivity and specificity to identify cancer cells compared to other non-cytological Circulating Tumor Cell tests available anywhere in the world, evident in more than 80 peer-reviewed articles published worldwide. We at NIIM are the first Institute in Australia to have acquired this technology and Michael has brought us together.”

AProf Dr Karin Ried
PhD MSc GDPH Cert Integrat Medicine
Research Director
National Institute of Integrative Medicine, Melbourne, Australia

Honorary Visiting Research Fellow, University of Adelaide, SA

Honorary Adjunct A/Prof, Bond University, QLD